AbbVie Inc. vs Eli Lilly and Company
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Eli Lilly and Company is the larger company by market value: $1.20 T against $514.0 B for AbbVie Inc., 2.3 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Oct 26, 2026 for Eli Lilly and Company).
- Eli Lilly and Company had more revenue: $65.2 B against $61.2 B for AbbVie Inc., both in the year to December 2025.
- Eli Lilly and Company earned more: net income of $20.6 B against $4.2 B for AbbVie Inc.
- Eli Lilly and Company keeps more of each dollar of sales: a net margin of 31.7% against 6.9% for AbbVie Inc.
- AbbVie Inc. employs more people: 57,000 against 50,000 at Eli Lilly and Company. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $1,303,580 at Eli Lilly and Company.
- On price to earnings, AbbVie Inc. trades at 49.7× and Eli Lilly and Company at 43.4×: investors pay more for each dollar of AbbVie Inc.'s profit.
- Eli Lilly and Company's revenue grew faster in its latest fiscal year: +44.7% against +8.6% for AbbVie Inc.
- On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and Eli Lilly and Company 7.
- Dividend yield: 2.27% for AbbVie Inc. and 0.45% for Eli Lilly and Company.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | AbbVie Inc. ABBV · #26 in the world | Eli Lilly and Company LLY · #13 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 2013 | 1876 |
| Size | ||
| Market cap | $514.0 B | $1.20 T |
| Revenue | $61.2 B | $65.2 B |
| Net income | $4.2 B | $20.6 B▲ best |
| Employees | 57,000 | 50,000 |
| Valuation | ||
| P/E ratio | 49.7× | 43.4× |
| Price to sales | 7.8× | 13.9× |
| Price to book | — | 45.1× |
| Free cash flow yield | 3.5% | — |
| Profitability | ||
| Gross margin | 70.2% | 83.0%▲ best |
| Operating margin | 24.6% | — |
| Net margin | 6.9% | 31.7%▲ best |
| Return on equity | — | 101.2% |
| Return on invested capital | 16.0% | — |
| Growth | ||
| Revenue growth | 8.6% | 44.7%▲ best |
| Revenue growth, 3 years a year | 1.8% | 31.7%▲ best |
| Earnings per share growth | -1.3% | 96.0%▲ best |
| Financial strength | ||
| Debt to equity | — | 1.5× |
| Interest cover | 5.2× | — |
| Cash | ||
| Free cash flow margin | 29.1% | — |
| Shareholder returns | ||
| Dividend yield | 2.3%▲ best | 0.5% |
| Shareholder yield | 2.5%▲ best | 0.8% |
| Strength scores | ||
| Piotroski F-score | 8 of 9▲ best | 7 of 9 |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, AbbVie Inc. or Eli Lilly and Company?
Eli Lilly and Company is the larger company by market value: $1.20 T against $514.0 B for AbbVie Inc., 2.3 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Oct 26, 2026 for Eli Lilly and Company).
Which makes more money, AbbVie Inc. or Eli Lilly and Company?
Eli Lilly and Company had more revenue: $65.2 B against $61.2 B for AbbVie Inc., both in the year to December 2025. Eli Lilly and Company earned more: net income of $20.6 B against $4.2 B for AbbVie Inc.
Which is more profitable, AbbVie Inc. or Eli Lilly and Company?
Eli Lilly and Company keeps more of each dollar of sales: a net margin of 31.7% against 6.9% for AbbVie Inc.
Which has more employees, AbbVie Inc. or Eli Lilly and Company?
AbbVie Inc. employs more people: 57,000 against 50,000 at Eli Lilly and Company. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $1,303,580 at Eli Lilly and Company.
Is AbbVie Inc. cheaper than Eli Lilly and Company?
On price to earnings, AbbVie Inc. trades at 49.7× and Eli Lilly and Company at 43.4×: investors pay more for each dollar of AbbVie Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
Which is growing faster, AbbVie Inc. or Eli Lilly and Company?
Eli Lilly and Company's revenue grew faster in its latest fiscal year: +44.7% against +8.6% for AbbVie Inc.
Which is financially stronger, AbbVie Inc. or Eli Lilly and Company?
On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and Eli Lilly and Company 7.
More about AbbVie Inc.
More about Eli Lilly and Company
- Eli Lilly and Company: company page
- Who owns Eli Lilly and Company?
- Eli Lilly and Company market cap history
- Eli Lilly and Company revenue by year
- How many employees does Eli Lilly and Company have?
- Is Eli Lilly and Company cheap or expensive?
- Eli Lilly and Company against its peers: ranks and percentiles
Sources#
Every figure on this page comes from these, with the date shown next to it.